These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2600498)

  • 21. [Relationship between apolipoprotein E and apolipoprotein B polymorphisms in youths with coronary heart disease].
    Li S; Lei ZW; Chen Z; Lin D; Ke XS; Zhong YM; Wu SF
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Jun; 20(3):241-3. PubMed ID: 12778454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Familial disorders of lipid metabolism in childhood].
    Herrmann W; Biermann J
    Z Arztl Fortbild (Jena); 1986; 80(17):725-8. PubMed ID: 3811401
    [No Abstract]   [Full Text] [Related]  

  • 23. Apolipoprotein E genotype and coronary heart disease.
    Batalla A; Alvarez R; Hevia S; Reguero JR; Coto E
    J Am Coll Cardiol; 2001 Jan; 37(1):329-31. PubMed ID: 11153762
    [No Abstract]   [Full Text] [Related]  

  • 24. Influence of polymorphisms for apolipoprotein B (ins/del, XbaI, EcoRI) and apolipoprotein E on serum lipids and apolipoproteins in a Javanese population.
    Gajra B; Candlish JK; Saha N; Heng CK; Soemantri AG; Tay JS
    Genet Epidemiol; 1994; 11(1):19-27. PubMed ID: 8013886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E as a risk factor for coronary heart disease: a genetic and molecular biology approach.
    de Knijff P; Havekes LM
    Curr Opin Lipidol; 1996 Apr; 7(2):59-63. PubMed ID: 8743896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Future genetic-epidemiological research in coronary heart disease: the decade of the apolipoproteins, dysapolipoproteinemia, and dyslipoproteinemia.
    Glueck CJ
    Prog Clin Biol Res; 1984; 147():525-32. PubMed ID: 6377319
    [No Abstract]   [Full Text] [Related]  

  • 27. Familial disorders of plasma apolipoproteins.
    Sirtori CR; Franceschini G
    Klin Wochenschr; 1985 Jun; 63(11):481-9. PubMed ID: 3925218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic hyperlipidemia and atherosclerosis.
    Stone NJ
    Artery; 1979 May; 5(5):377-97. PubMed ID: 262162
    [No Abstract]   [Full Text] [Related]  

  • 29. Apolipoprotein E (role in lipoprotein metabolism and pathophysiology of hyperlipoproteinemia type III).
    Utermann G
    Ric Clin Lab; 1982; 12(1):23-30. PubMed ID: 6283616
    [No Abstract]   [Full Text] [Related]  

  • 30. Apolipoprotein B, apolipoprotein E, and angiotensin-converting enzyme polymorphisms in 2 Italian populations at different risk for coronary artery disease and comparison of allele frequencies among European populations.
    Corbo RM; Scacchi R; Mureddu L; Mulas G; Castrechini S; Rivasi AP
    Hum Biol; 1999 Dec; 71(6):933-45. PubMed ID: 10592684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein E phenotypes and hyperlipidemia.
    Utermann G; Kindermann I; Kaffarnik H; Steinmetz A
    Hum Genet; 1984; 65(3):232-6. PubMed ID: 6698547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Genotyping of hyperlipoproteinemia].
    Matsushima T
    Nihon Rinsho; 1994 Dec; 52(12):3203-9. PubMed ID: 7853711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrate.
    Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Cariolou M; Ganotakis ES; Mikhailidis DP; Elisaf MS
    J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):211-21. PubMed ID: 17056835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of apolipoprotein E polymorphism on the tracking of childhood levels of serum lipids and apolipoproteins over a 6-year period. The Bogalusa Heart Study.
    Srinivasan SR; Ehnholm C; Wattigney WA; Berenson GS
    Atherosclerosis; 1996 Nov; 127(1):73-9. PubMed ID: 9006807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein E polymorphism and coronary heart disease.
    Ashavaid TF; Todur SP; Nair KG
    J Assoc Physicians India; 2003 Aug; 51():784-8. PubMed ID: 14651139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular basis of type III hyperlipoproteinemia in Germany.
    Feussner G; Feussner V; Hoffmann MM; Lohrmann J; Wieland H; März W
    Hum Mutat; 1998; 11(6):417-23. PubMed ID: 9603433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Disorders of apolipoproteins and lipoprotein receptors].
    Itakura H; Matsumoto A
    Nihon Rinsho; 1990 Nov; 48(11):2666-74. PubMed ID: 2125327
    [No Abstract]   [Full Text] [Related]  

  • 38. Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification.
    Zannis VI; Breslow JL
    Biochemistry; 1981 Feb; 20(4):1033-41. PubMed ID: 6260135
    [No Abstract]   [Full Text] [Related]  

  • 39. [Association of psoriasis with hyperlipoproteinemia, stroke, ischemic heart disease, myocardial infarct and diabetes mellitus].
    Mordovtsev VN; Sergeev AS; Alieva PM; Koshechkin VA
    Vestn Dermatol Venerol; 1982 Sep; (9):4-8. PubMed ID: 7180190
    [No Abstract]   [Full Text] [Related]  

  • 40. Apolipoprotein E and A-IV polymorphisms in the Estonian population.
    Lehtimäki T; Uibu T; Roto P; Koivula T; Jokela H; Ehnholm C; Peltonen N; Nikkari T
    Clin Genet; 1998 Jul; 54(1):106-7. PubMed ID: 9727753
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.